Form 4: Carlyle Group Sells Shares of QuidelOrtho Corp (QDEL) Under 10b5-1 Trading Plan

Carlyle Group Inc. reports the sale of QuidelOrtho Corp shares across multiple transactions on July 24 and 25, 2024, executed under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Carlyle Group Inc. and related entities have reported the sale of QuidelOrtho Corp (QDEL) common stock.
• The sales occurred on July 24 and 25, 2024.
• The transactions were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• A total of 619,541 shares were sold across the two days.
• The sales were conducted at weighted average prices ranging from $37.77 to $39.80 per share.
• Following the reported transactions, Carlyle Partners VI Cayman Holdings, L.P. indirectly holds 9,706,231 shares of QuidelOrtho Corp.
• The reporting entities disclaim beneficial ownership of the securities.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing share sales. It doesn't inherently convey positive or negative sentiment, but rather reports factual transactions. The use of a 10b5-1 plan suggests a planned and orderly disposal of shares.

Industry Context

Share sales by major holders like Carlyle Group are common and can be driven by various factors, including portfolio rebalancing or profit-taking. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on recent market information.

Stakeholder Impact

• The share sales could potentially exert downward pressure on QuidelOrtho's stock price in the short term.
• The sales by a major shareholder like Carlyle Group may influence investor sentiment.

Key Dates